Abstract
To prevent cardiovascular disease, targeting aldosterone synthesis and release may be clinically important. Aldosterone production in the adrenal gland is mediated mainly by the T-type calcium channel in vitro. Efonidipine inhibits both L- and T-type Ca channels. To compare the effects of efonidipine on neurohumoral factors with those of amlodipine, an L-type Ca channel blocker, we studied 40 essential hypertensive outpatients. Forty patients who had been administered amlodipine for more than 1 year were treated with efonidipine for 6 months in place of amlodipine. Substituting efonidipine for amlodipine had no significant effect on clinic systolic blood pressure or the plasma levels of brain natriuretic peptide, norepinephrine or active renin. However, the heart rate was significantly decreased (72.0±1.3 vs. 69.8±1.3 beats/min, p<0.01) and the plasma aldosterone level was also significantly decreased after efonidipine treatment (97.7±7.9 vs. 79.7±5.6 pg/mL, p<0.0001). Changes in the aldosterone level correlated with the baseline value before the replacement of amlodipine by efonidipine (r=−0.769, p<0.0001). These findings indicate that at the effective antihypertensive doses of efonidipine and amlodipine, efonidipine significantly decreases heart rate and plasma aldosterone level compared with those under amlodipine treatment in hypertensive patients.
Similar content being viewed by others
Article PDF
References
Minami J, Ishimitsu T, Kawano Y, Matsuoka H : Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients. Clin Exp Pharmacol Physiol 1998; 25: 572–576.
Tsutamoto T, Tsutsui T, Maeda K, et al: Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine. J Cardiovasc Pharmacol 2003; 41 ( Suppl 1): S77–S81.
McKelvie RS, Yusuf S, Pericak D, et al, The RESOLVD Pilot Study Investigators : Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Circulation 1999; 100: 1056–1064.
Krum H, Nolly H, Workman D, et al: Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients. Hypertension 2002; 40: 117–123.
Tsutamoto T, Wada A, Maeda K, et al: Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 2001; 37: 1228–1233.
Weber KT : Cardioreparation in hypertensive heart disease. Hypertension 2001; 38: 588–591.
Vasan RS, Evans JC, Benjamin EJ, et al: Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 2004; 43: 957–962.
Brunner HR, Laragh JH, Baer L, et al: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972; 286: 441–449.
Swedberg K, Eneroth P, Kjekshus J, Snapinn S, CONSENSUS Trial Study Group: Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). Am J Cardiol 1990; 66: 40D–45D.
Cohn JN, Anand IS, Latini R, Masson S, Chiang YT, Glazer R : Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial. Circulation 2003; 108: 1306–1309.
Barrett PQ, Isales CM, Bollag WB, McCarthy RT : Ca2+ channels and aldosterone secretion: modulation by K+ and atrial natriuretic peptide. Am J Physiol 1991; 261: F706–F719.
Rossier MF, Burnay MM, Vallotton MB, Capponi AM : Distinct functions of T- and L-type calcium channels during activation of bovine adrenal glomerulosa cells. Endocrinology 1996; 137: 4817–4826.
Rossier MF, Ertel EA, Vallotton MB, Capponi AM : Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. J Pharmacol Exp Ther 1998; 287: 824–831.
Chen XL, Bayliss DA, Fern RJ, Barrett PQ : A role for T-type Ca2+ channels in the synergistic control of aldosterone production by ANG II and K+. Am J Physiol 1999; 276: F674–F683.
Lesouhaitier O, Chiappe A, Rossier MF : Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression. Endocrinology 2001; 142: 4320–4330.
Imagawa K, Okayama S, Takaoka M, et al: Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells. J Cardiovasc Pharmacol 2006; 47: 133–138.
Okayama S, Imagawa K, Naya N, et al: Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers. Hypertens Res 2006; 29: 493–497.
Tsutamoto T, Wada A, Maeda K, et al: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509–516.
The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–1435.
Cohn JN, Johnson G, Ziesche S, et al: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–310.
Pitt B, Zannad F, Remme WJ, et al, Randomized Aldactone Evaluation Study Investigators : The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709–717.
Hayashi M, Tsutamoto T, Wada A, et al: Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001; 37: 1820–1826.
Hayashi M, Tsutamoto T, Wada A, et al: Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1375–1382.
Pitt B, Remme W, Zannad F, et al: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309–1321.
Hayashi M, Tsutamoto T, Wada A, et al: Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 2003; 107: 2559–2565.
Rossier MF, Lesouhaitier O, Perrier E, Bockhorn L, Chiappe A, Lalevee N : Aldosterone regulation of T-type calcium channels. J Steroid Biochem Mol Biol 2003; 85: 383–388.
Lalevee N, Rebsamen MC, Barrere-Lemaire S, et al: Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 2005; 67: 216–224.
Wagner C, Kramer BK, Hinder M, Kieninger M, Kurtz A : T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. Br J Pharmacol 1998; 124: 579–585.
Karam H, Clozel JP, Bruneval P, Gonzalez MF, Menard J : Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Hypertension 1999; 34: 673–678.
Lamarre-Cliche M, de Champlain J, Lacourciere Y, Poirier L, Karas M, Larochelle P : Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. Am J Hypertens 2005; 18: 56–64.
Schweda F, Kurtz A : Cellular mechanism of renin release. Acta Physiol Scand 2004; 181: 383–390.
Schunkert H, Hense HW, Muscholl M, et al: Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 1997; 77: 24–31.
Vasan RS, Evans JC, Larson MG, et al: Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351: 33–41.
Kario K, Yasui N, Yokoi H : Ambulatory blood pressure monitoring for cardiovascular medicine. IEEE Eng Med Biol Mag 2003; 22: 81–88.
Gillman MW, Kannel WB, Belanger A, D'Agostino RB : Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125: 1148–1154.
Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S : Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Circ J 2003; 67: 139–145.
Martinez ML, Heredia MP, Delgado C : Expression of T-type Ca2+ channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 1999; 31: 1617–1625.
Mulder P, Richard V, Compagnon P, et al: Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure. J Am Coll Cardiol 1997; 29: 416–421.
Huang B, Qin D, Deng L, Boutjdir M, El-Sherif N : Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 2000; 46: 442–449.
Sen L, Smith TW : T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994; 75: 149–155.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, T., Tsutamoto, T., Sakai, H. et al. Comparison of the Effects of Efonidipine and Amlodipine on Aldosterone in Patients with Hypertension. Hypertens Res 30, 691–697 (2007). https://doi.org/10.1291/hypres.30.691
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.691
Keywords
This article is cited by
-
Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine
Journal of Pharmacokinetics and Pharmacodynamics (2012)
-
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria
Hypertension Research (2011)
-
Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis
Hypertension Research (2011)
-
Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats
Hypertension Research (2010)
-
Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine
Hypertension Research (2010)